HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Axe Shower Gels Take A Swing At The U.S. Market

This article was originally published in The Rose Sheet

Executive Summary

Unilever is aiming for Axe to build an even stronger position in the U.S. personal care market with the introduction of Axe shower gels, rolling out now

You may also be interested in...



The Evolution Of Unilever's AXE: From Babe Magnet To Personal Guru

AXE is taking a "bold new direction" with its marketing, encouraging men to celebrate their uniqueness and look to AXE for its product innovations and grooming advice, rather than the brand's irresistible aphrodisiac powers promoted in the past. The Unilever unit is targeting new "Find Your Magic" messaging to consumers in the US and abroad with cross-channel advertising, including a video created by 72andSunny Amsterdam.

P&G’s Gillette Announces Line Extensions, Stays Abreast With Unilever’s Axe

Gillette's growth strategy continues to mirror that formula for success provided by competitor Axe since 2002 when the brand elevated the "game" of teenaged American males by launching its fragranced body sprays in the U.S

P&G’s Gillette Announces Line Extensions, Stays Abreast With Unilever’s Axe

Gillette's growth strategy continues to mirror that formula for success provided by competitor Axe since 2002 when the brand elevated the "game" of teenaged American males by launching its fragranced body sprays in the U.S

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012863

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel